Few fields of innovation are as labor-intensive or impactful
as pharmacy. While groundbreaking new drugs grab headlines, much of
today's quiet therapeutic progress comes from discovering new
ways to apply existing compounds. These so-called second medical
uses can offer critical treatments for previously unaddressed
ailments, but their patentability is often complex and varies from
country to country.
In Brazil, where Swiss-type patent claims are permitted under
certain conditions, the approach to protecting such advances
reflects a careful balance between research, competition and public
health.
The protection afforded by Swiss-type patent claims is vital for
incentivizing the development of inventions directed to second
medical uses. These innovations involve the use of a known
compound, composition or similar substance for a new therapeutic
purpose, specifically, in the treatment of a disease, disorder or
health condition that is different from its previously
